Pinealon Dosage Guide, Benefits & Side Effects

Pinealon is not FDA-approved for any human medical use and is not a controlled substance under the U.S. Controlled Substances Act. It is commonly sold labeled 'for research use only, not for human consumption,' typically to researchers or institutions rather than as a consumer health product. Regulatory status can vary by country and can change, so anyone considering it should check current local regulations rather than relying on vendor marketing claims.

As with most peptides sold in research contexts, the lyophilized (freeze-dried) powder is generally recommended to be stored frozen (around -20°C) for long-term stability before reconstitution. Once reconstituted with bacteriostatic or sterile water, it is commonly recommended to refrigerate (2-8°C) and use within about 2-4 weeks, since peptides degrade faster at room temperature and lose potency over time. Exact stability data specific to Pinealon has not been independently verified through published studies, so these are general peptide-handling conventions rather than manufacturer-verified shelf-life claims.

Within research and biohacking communities, Pinealon is frequently discussed alongside other Khavinson-group bioregulator peptides, most notably Epitalon (Epithalon), which is studied for effects related to the sleep-melatonin cycle and telomerase activity, and sometimes DSIP (delta sleep-inducing peptide). These are often grouped together informally as 'pineal peptides' for sleep- and aging-related research interest, but there is no clinical trial evidence establishing safety or effects of combining them, and any such stacking reflects community practice rather than validated protocols.

The evidence base for Pinealon comes almost entirely from a single research lineage (the Khavinson Institute of Bioregulation and Gerontology), including preclinical (animal/cell) studies and a small number of published human studies, such as a study in patients with traumatic brain injury consequences. This research reports neuroprotective and antioxidant effects and modulation of circadian/melatonin-related pathways, but independent replication by other research groups is essentially absent from peer-reviewed Western literature, and no large controlled human trials exist. As a result, claims about its effectiveness for memory, sleep, or brain health in humans should be treated as preliminary and unproven rather than established, and it is not intended or approved as a treatment for any condition.